Mesothelioma Cancer Resources Blog
-
Mesothelioma Patients May Benefit From Use of Painkiller That Shows Ability to Fight Cancer
Last week MesotheliomaCounsel reported on the potential cancer-fighting benefits of aspirin. Now, researchers report that another painkiller, used to treat migraines and arthritis, has “significant anti-cancer properties.” The drug, that can also boost the immune system, may offer mesothelioma patients another option for treatment. In a Jan. 11 press release from the AntiCancer Fund, an …
Label: Featured Story
Posted on Thursday, Jan 28, 2016 -
Aspirin Clinical Trial Could Lead to Early Treatment Guidelines for Mesothelioma
For years, researchers and medical professionals have touted the benefits of aspirin. Often the go-to drug for minor aches and pains, aspirin is also prescribed as a daily antidote to help lower the risk of heart attack. Others claim a daily aspirin may reduce the incidence of cancers. Now, researchers in the UK are putting …
Label: Featured Story
Posted on Thursday, Jan 21, 2016 -
Mesothelioma Patients Stand to Benefit from FDA Approval of Keytruda as First Line Treatment for Melanoma
The unprecedented results for mesothelioma and melanoma patients being treated with Keytruda (pembrolizumab) have kept the drug in the spotlight over the last year. The benefits of the drug are continuing to impress as the U.S. Food and Drug Administration announced last month that Keytruda is now approved for first-line treatment in melanoma patients. FDA …
Label: Featured Story
Posted on Monday, Jan 18, 2016